OneTouch Verio Regulatory Update in the US

31 Dec 2010

Universal Biosensors, Inc. (ASX: UBI) has been advised by LifeScan, Inc. that LifeScan has been granted regulatory clearance to sell the OneTouch Verio® product as sold in Australia by the United States Food and Drug Administration.

Chairman and Interim CEO, Andrew Denver noted “We are pleased that the FDA has approved the Verio system. It is another step in the commercialisation of the UBI developed product. However it must be noted that LifeScan have not disclosed their plans for a US launch, a decision which is solely within their control.”

Read the full report

All News